AIP
BLU

Almanack Investment Partners’s BELLUS Health Inc. BLU Stock Holding History

Almanack Investment Partners’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,046
Closed -$11K – 848
2022
Q3 		$11K Buy
+1,046
New +$11.1K ﹤0.01% 470

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Almanack Investment Partners's BLU Position: Q4 2022 in Review

Almanack Investment Partners sold out of BELLUS Health Inc. (BLU) in Q4 2022, closing a stake of 1,046 shares — an estimated $11K sold.

Almanack Investment Partners first reported a position in BLU in Q3 2022 and held it in 1 quarter. The position peaked at $11K in Q3 2022. 121 funds tracked by Wall St. Rank hold BLU as of Q4 2022.

  • Almanack Investment Partners reported no remaining BELLUS Health Inc. position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 1,046 BELLUS Health Inc. shares in Q4 2022, an estimated $11K.
  • Almanack Investment Partners first reported a position in BELLUS Health Inc. in Q3 2022 and held it in 1 quarter.
  • Almanack Investment Partners's BELLUS Health Inc. position peaked at $11K in Q3 2022.
  • 121 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.